1. Fromtling, R. A. In vitro methods in the evaluation of antifungal agents. In: Fromtling, R. A. (ed.) Recent trends in the discovery, development and evaluation of antifungal agents. J. R. Prous, Barcelona, 1987, p. 7–14.
2. Shadomy, S. Preclinical evaluation of antifungal agents: design of in vitro screens. In: Fromtling, R. A. (ed.) Recent trends in the discovery, development and evaluation of antifungal agents. J. R. Prous, Barcelona, 1987, p. S1: 1-S1: 10.
3. Doern, G. V., Tubert, T. A., Chapin, K., Rinaldi, M. G. Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts. Journal of Clinical Microbiology 1986, 24: 507–511.
4. Galgiani, J. N., Reiser, J., Brass, C., Espinel-Ingroff, A., Gordon, M. A., Kerkering, T. M. Comparison of relative susceptibilities ofCandida species to three antifungal agents as determined by unstandardized methods. Antimicrobial Agents and Chemotherapy 1987, 31: 1343–1347.
5. Odds, F. C., Abbott, A. B., Pye, G., Troke, P. F. Improved method for estimation of azole antifungal inhibitory concentrations againstCandida species, based on azole/antibiotic interactions. Journal of Medical and Veterinary Mycology 1986, 24: 305–311.